期刊文献+

AURKA对多发性骨髓瘤细胞增殖和凋亡及药物敏感性的影响及其机制

Effect and mechanism of AURKA on proliferation,apoptosis and drug sensitivity of multiple myeloma cells
原文传递
导出
摘要 目的探讨AURKA对多发性骨髓瘤(MM)细胞增殖、凋亡、周期改变及对药物敏感性的影响,并分析内在机制。方法人多发性骨髓瘤细胞株RPMI8226和U266分别转染smart silencer NC(ssi-NC)和smart silencer AURKA(ssi-AURKA),分为ssi-NC组、ssi-AURKA组和空白组,采用实时荧光定量聚合酶链式反应(qRT-PCR)和蛋白质印迹实验检测3组细胞AURKA mRNA和AURKA蛋白相对表达量,细胞计数试剂盒8(CCK8)检测其细胞增殖活性,流式细胞术检测ssi-NC组、ssi-AURKA组细胞周期变化和凋亡率,CCK 8法检测其对硼替佐米和地塞米松的药物敏感性,蛋白质印迹实验检测Wnt信号通路相关因子及上皮细胞-间充质转化(EMT)相关蛋白表达。结果RPMI8226细胞ssi-AURKA组蛋白相对表达量为0.58±0.09,低于空白组(1.00±0.10)和ssi-NC组(1.00±0.09),F=20.84,P<0.001;U266细胞ssi-AURKA组蛋白相对表达量为0.57±0.07,低于空白组(1.00±0.04)和ssi-NC组(1.07±0.08),F=46.19,P<0.001。细胞增殖活性实验结果显示RPMI8226细胞空白组、ssi-NC组、ssi-AURKA组相对活性差异有统计学意义,F_(时间)=3966.12,P_(时间)<0.001;F_(组别)=363.15,P_(组别)<0.001;F_(时间×组别)=48.03,P_(时间×组别)<0.001。U266细胞空白组、ssi-NC组、ssi-AURKA组相对活性差异有统计学意义,F_(时间)=2452.32,P_(时间)<0.001;F_(组别)=236.91,P_(组别)<0.001;F_(时间×组别)=33.47,P_(时间×组别)<0.001。RPMI8226细胞和U266细胞中ssi-AURKA组S期均增加,t值分别为12.28和14.64,均P<0.001;G_(0)/G_(1)期均降低,t值分别为23.33和22.98,均P<0.001。RPMI8226细胞(t=16.23,P<0.001)和U266细胞(t=18.44,P<0.001)中,与ssi-NC组比较,ssi-AURKA组细胞总凋亡率增加。药物敏感性实验结果显示,RPMI8226细胞ssi-NC组、ssi-AURKA组、ssi-NC+B+D组、ssi-AURKA+B+D组细胞活性差异有统计学意义,F_(时间)=618.82,P_(时间)<0.001;F_(组别)=1373.51,P_(组别)<0.001;F_(时间×组别)=228.70,P_(时间×组别)<0.001。U266细胞ssi-NC组、ssi-AURKA组、ssi-NC Objective To explore the effects of AURKA on proliferation,apoptosis,cycle changes and drug sensitivity of multiple myeloma(MM)cells,and analyze the underlying mechanisms.Method Human multiple myeloma cell lines RPMI8226 and U266 were transfected with smart silent NC(ssi-NC)and smart silent AURKA(ssi-AURKA)respectively.They were divided into ssi-NC group,ssi-AURKA group and blank group.Real time fluorescence quantitative polymerase chain reaction(qRT-PCR)and western blotting were used to detect the relative expression levels of AURKA mRNA and AURKA protein in the three groups of cells.The cell proliferation activity was detected by CCK8 method,and the cell cycle changes and apoptosis rate were detected by flow cytometry in the ssi-NC group and ssi-AURKA group.The drug sensitivity to bortezomib and dexamethasone was evaluated by CCK 8 assay.Western blotting was performed to detect the expression of Wnt signaling pathway related factors and epithelial mesenchymal transition(EMT)related proteins.Results The relative expression level of ssi-AURKA histone in RPMI8226 cells was 0.58±0.09,lower than that of the blank group(1.00±0.10)and ssi-NC group(1.00±0.09),F=20.84,P<0.001;The relative expression level of ssi-AURKA histone in U266 cells was 0.57±0.07,lower than that of the blank group(1.00±0.04)and ssi-NC group(1.07±0.08),F=46.19,P<0.001.The results of the cell proliferation activity experiment showed that there was a statistically significant difference in the relative activity of RPMI8226 cells among the blank group,ssi-NC group and ssi-AURKA group,F_(time)=3966.12,P_(time)<0.001;F_(group)=363.15,P_(group)<0.001;F_(time×group)=48.03,P_(time×group)<0.001.There was a statistically significant difference in relative cell activity among the U266 cell blank group,ssi-NC group and ssi-AURKA group,with F_(time)=2452.32 and P_(time)<0.001;F_(group)=236.91,P_(group)<0.001;F_(time×group)=33.47,P_(time×group)<0.001.The S phase of the ssi-AURKA group in RPMI8226 cells and U266 cells were increased,with t-values of 12
作者 刘红春 黄睿 许腾 黄国虹 LIU Hongchun;HUANG Rui;XU Teng;HUANG Guohong(Clinical Laboratory Center,Xinjiang Uygur Autonomous Region People's Hospital,Urumqi,Xinjiang 830002,China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2024年第14期865-873,共9页 Chinese Journal of Cancer Prevention and Treatment
基金 新疆维吾尔自治区自然科学基金面上项目(2021D01C135) 新疆维吾尔自治区人民医院院内项目(20200209)
关键词 多发性骨髓瘤 AURKA 耐药 增殖 凋亡 WNT信号通路 multiple myeloma AURKA drug resistance proliferation apoptosis Wnt signaling pathway
  • 相关文献

参考文献18

二级参考文献67

  • 1郑元,仇惠英,许丽萍,丰斌,潘金兰,薛永权.荧光原位杂交检测多发性骨髓瘤18号染色体异常[J].临床检验杂志,2006,24(3):215-215. 被引量:5
  • 2Debes-Marun CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelo ma[J]. Leukemia, 2003,17 ( 2 ): 427-436. 被引量:1
  • 3P e rez-Sim 6 n JA, Garc i a-Sanz R, Tabernero MD, et al.Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes[J].Blood, 1998,91 ( 9 ): 3366-3371. 被引量:1
  • 4Chiecchin L, Dagrada GP, Ibrahim AH, et a l. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context[.l].Haematologica, 2009,94 ( 12 ): 1708-1713. 被引量:1
  • 5Fonseca R, Oken MM, Harrington D, el al.Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy[J].Leukemia, 2001,15 ( 6 ) : 981-986. 被引量:1
  • 6Shaughnessy J, Tian E, Sawyer J, et al.High incidence of chromosome 13 deletion in multiple myeloma detected by mulliprobe intei31hase F1SH[J].Blood, 2000,96 (4): 1505-1511. 被引量:1
  • 7I Yuregir 00, Sahin FI, Yilmaz Z , el al.Fluorescent in situ hyhridizalion studies in multiple myeloma[J].Hematology, 2009,14 ( 2 ) : 90-94. 被引量:1
  • 8Takimoto M, Ogawa K, Kato Y, et al.Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 1 lql3/CCND1 and 16q23/MAF[J].Int J Hematol 2008,87 ( 3 ): 260-265. 被引量:1
  • 9Janssen JWG, Vaandrager JW, Heuser T, et al.Concurrent activation of a novel putative transfnrming gene, myeov, and cyclin D 1 in a subset of multiple myeloma cell lines with t(11;14 )(q13;q32 )[J].Blood,2000,95 (8) 2691-269. 被引量:1
  • 10Tricot G, Barlogie B, Jagannath S, et al.Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities incolving 1 lq and not with other karyotype abnomalities[J]. Blood, 1995,86 ( 11 ): 4250-4256. 被引量:1

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部